TipRanks
Swedish Orphan Biovitrum AB (DE:B6E)
FRANKFURT:B6E
Germany Market
B6E
Swedish Orphan Biovitrum AB
RESEARCH TOOLSreports

Swedish Orphan Biovitrum AB (B6E) Stock News & Sentiment

5 Followers
Sobi Adjusts Share Capital to Support Employee Incentive Programme
Premium
Company Announcements
Sobi Adjusts Share Capital to Support Employee Incentive Programme
1d ago
Sobi: Advancing Pacritinib Pipeline Supports Asymmetric Upside With Buy Rating and Maintained SEK575 Target
Premium
Ratings
Sobi: Advancing Pacritinib Pipeline Supports Asymmetric Upside With Buy Rating and Maintained SEK575 Target
21d ago
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
Premium
Company Announcements
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
1M ago
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
Premium
Ratings
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
1M ago
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
2M ago
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
Premium
Company Announcements
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
2M ago
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
Premium
Ratings
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
2M ago
More DE:B6E News >

B6E News on the Web

Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
TipRanks News
Bullish
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
TipRanks News
Bullish
Sobi CEO Guido Oelkers to Step Down in Early 2027
TipRanks News
Bullish
Q2 2026 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
GuruFocus News
Neutral
Swedish Orphan Biovitrum AB (BIOVF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus News
Bullish
Swedish Orphan Biovitrum price target raised to SEK 575 at Berenberg
TipRanks News
Bullish
Sobi lifts 2026 outlook as Q2 revenue surges and gout pipeline advances
TipRanks News
Bullish
Sobi Moves to Repurchase Class C Shares to Support Employee Incentive Programme
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:B6E
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:B6E’s Media Buzz Sentiment?
1 articles about DE:B6E were published this week. In an average week, 1 articles are published.
    What is DE:B6E’s weekly average amount of articles?
    In an average week, 1 articles about DE:B6E are published.
      What is DE:B6E’s News Sentiment?
      100% of articles about DE:B6E were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week